骨肉瘤
生物相容性
骨科手术
骨癌
生物医学工程
材料科学
癌症
医学
类骨质
植入
癌症研究
纳米技术
病理
外科
内科学
冶金
作者
Xiao Hu,Chunhai Ke,Jiaqi Zhong,Yujiong Chen,Jieyang Dong,Mingming Hao,Qi Chen,Jiahua Ni,Zhaoxiang Peng
标识
DOI:10.3389/fbioe.2023.1252816
摘要
Osteosarcoma, the most common primary malignant bone tumor, is characterized by malignant cells producing osteoid or immature bone tissue. Most osteosarcoma patients require reconstructive surgery to restore the functional and structural integrity of the injured bone. Metal orthopedic implants are commonly used to restore the limb integrity in postoperative patients. However, conventional metal implants with a bioinert surface cannot inhibit the growth of any remaining cancer cells, resulting in a higher risk of cancer recurrence. Herein, we fabricate a selenium-doped TiO 2 nanotube array (Se-doped TNA) film to modify the surface of medical pure titanium substrate, and evaluate the anti-tumor effect and biocompatibility of Se-doped TNA film. Moreover, we further explore the anti-tumor potential mechanism of Se-doped TNA film by studying the behaviors of human osteosarcoma cells in vitro . We provide a new pathway for achieving the anti-tumor function of orthopedic implants while keeping the biocompatibility, aiming to suppress the recurrence of osteosarcoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI